Betahistini Dihydrochloride
Betahistyne Bluefish and Beta-histina Bluefish are different trade names for the same medicine.
The active substance in Betahistyne Bluefish is betahistini dihydrochloride. This medicine is called a "histamine analogue". The medicine is used to treat:
Symptoms of Meniere's disease, such as vertigo of vestibular origin, tinnitus, hearing loss with accompanying nausea, hearing disturbances, and/or headache:
This medicine must not be taken if the patient has any of these conditions. Before taking Betahistyne Bluefish, the patient should talk to their doctor or pharmacist.
Before taking Betahistyne Bluefish, the patient should discuss it with their doctor.
Before taking Betahistyne Bluefish, the patient should talk to their doctor or pharmacist.
This medicine must not be taken if the patient has any of these conditions (or is unsure). Before taking Betahistyne Bluefish, the patient should talk to their doctor or pharmacist. It may be necessary to closely monitor the patient's condition while taking Betahistyne Bluefish.
Children
Betahistyne Bluefish is not recommended for children.
The patient should tell their doctor or pharmacist about all medicines they are taking, have recently taken, or might take.
In particular, the patient should inform their doctor or pharmacist if they are taking any of the following medicines:
Betahistyne Bluefish can be taken with or without food. However, Betahistyne Bluefish may cause mild stomach upset (see section 4). Taking Betahistyne Bluefish with food may help reduce stomach upset.
If the patient is pregnant or breast-feeding, thinks they may be pregnant, or plans to have a baby, they should ask their doctor or pharmacist for advice before taking this medicine.
It is not known whether Betahistyne Bluefish affects the unborn child:
It is not known whether betahistine passes into breast milk.
It is unlikely that Betahistyne Bluefish will affect the ability to drive or use machines. However, the patient should remember that the diseases being treated with Betahistyne Bluefish (vertigo, tinnitus, and hearing loss associated with Meniere's disease) can cause a feeling of spinning and nausea, which may affect the ability to drive or use machines.
This medicine should always be taken exactly as advised by the doctor or pharmacist. If the patient has any doubts, they should ask their doctor or pharmacist. The doctor will adjust the dose individually for each patient.
Betahistyne Bluefish is available in the following strengths: 8 mg, 16 mg, 24 mg.
The recommended dose is: half a tablet or one tablet, 3 times a day.
The patient should always follow the doctor's advice, as the doctor may adjust the dose.
If the patient takes more than one tablet a day, they should spread the tablets evenly throughout the day.
The patient should try to take a tablet at the same time every day. This will help ensure that a steady amount of medicine is in the body. Taking the tablets at the same time will also help the patient remember to take them.
If the patient takes too many Betahistyne Bluefish tablets, they may experience nausea, drowsiness, or stomach pain. If the patient has any doubts, they should ask their doctor.
If the patient forgets to take a tablet, they should skip that dose. They should wait until it is time for their next dose. The patient should not take a double dose to make up for a missed tablet.
The patient should not stop taking Betahistyne Bluefish without consulting their doctor, even if they feel better.
If the patient has any further doubts about the use of this medicine, they should ask their doctor or pharmacist.
Like all medicines, Betahistyne Bluefish can cause side effects, although not everybody gets them.
If an allergic reaction occurs (frequency not known), the patient should stop taking Betahistyne Bluefish and contact their doctor or go to the nearest hospital immediately. Symptoms may include:
Common(may affect up to 1 in 10 people):
Unknown(frequency cannot be estimated from the available data):
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
There are no special precautions for storage.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
White, round, biconvex, uncoated tablets, 8.6 mm - 8.8 mm in size, with a score line on one side and the marking "I" on both sides of the score line and a smooth surface on the other side.
PVC/PVDC/Aluminum blisters: 20, 30, 50, 60, 90, and 100 tablets.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Bluefish Pharmaceuticals AB
P.O. Box 49013
100 28 Stockholm
Sweden
Bluefish Pharmaceuticals AB
Gävlegatan 22
113 30 Stockholm
Sweden
InPharm Sp. z o.o., ul. Strumykowa 28/11, 03-138 Warsaw
InPharm Sp. z o.o. Services sp. k., ul. Chełmżyńska 249, 04-458 Warsaw
Authorization Number in Portugal, the Country of Export:5681846
Member State | Medicinal Product Name |
Portugal (RMS) | Beta-histina Bluefish |
Poland | Betahistyna Bluefish |
Spain | Betahistina Bluefish 16 mg comprimidos EFG |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.